Dr. Paul emphasised landmark contributions by Indian geneticists in discovering novel gene therapies for Sickle Cell Disease and small molecules for the treatment of some other rare genetic diseases.
Casey McPherson, Founder and CEO of Chrysalis Genetics, talks about his daughter's rare genetic condition, and how it led him to antisense oligonucleotides (ASOs) and therapeutic development for rare ...